Literature DB >> 33984157

Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis.

Arushi Khurana1, Joanna C Dalland2, Jason R Young3, David J Inwards1, Jonas Paludo1.   

Abstract

Entities:  

Year:  2021        PMID： 33984157     DOI： 10.1002/ajh.26233

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

Review 1.  Development and clinical translation of ex vivo gene therapy.

Authors:  Xiaomo Wu; Xiaorong He; Fahui Liu; Xiaochang Jiang; Ping Wang; Jinyan Zhang; Ju Jiang
Journal:  Comput Struct Biotechnol J       Date:  2022-06-11       Impact factor: 6.155

2.  Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy.

Authors:  Huanpeng Chen; Yuying Yang; Yuqing Deng; Fengjiao Wei; Qingyu Zhao; Yongqi Liu; Zhonghua Liu; Bolan Yu; Zhaofeng Huang
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.